Market Currents
Johnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from...
-
Friday, January 4, 9:04 AM ETJohnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from $75, at Deutsche Bank, which cites improving sales trends and benefits of diversification. Recent and new drugs should continue to drive pharma sales, and JNJ should continue to work through the McNeil Consent Decree and return consumer products to market. JNJ +0.6% premarket.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: